Clinical Trials
2 trialsNCT00052507 2015-07-23
Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer
University Health Network, Toronto
Phase 2 Completed
NCT00051987 2008-02-11
Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma
Millennium Pharmaceuticals, Inc.
Phase 2 Completed